Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Key Players companies in Enzalutamide
by Most Literature Citation in the United Kingdom in 2022

The Enzalutamide top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Literature Citation Enzalutamide Key Players in the United Kingdom. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Enzalutamide is used to treat men with a certain type of prostate cancer.

Key Players

Fast-growings

Startups & Unicorns

New Entrants

Ranking Year:

2022

2021

2020

2019

2018

Region:

Global

Canada

Belgium

United States

United Kingdom

Ranking:

Most Research Publications

Most Literature Citation

Most Market Reports

Most News Heat

#
Company Name
Region
Tech Topics
Total
1
AstraZeneca Plc
Cambridgeshire, United Kingdom
Medicine,Health care,Side effect,
...[+2]
Literature citation: 659
2
IQVIA Ltd.
United Kingdom
Health information technology,Contract research organization,Clinical research,
...[+2]
Literature citation: 263
3
Clatterbridge Cancer Centre NHS Foundation Trust
United Kingdom
Chemotherapy,Health care,Hospitality industry
Literature citation: 123
4
Guy's Hospital
GL, GB
Health science
Literature citation: 67
5
Southampton General Hospital
Hampshire, United Kingdom
Health care,Hospitality industry,Dendritic cell,
...[+2]
Literature citation: 12

Who we serve

R&D Decision MakersNew Product Innovation LeaderTechnology Research AnalystsBusiness Development Professionals

Why Discovery

Technology Intelligence Data FoundationAI-powered Competitive Intelligence RadarTechnology Classification and Company Innovation Indicators

Social media

Try Discovery

Free Trial
PatSnap group products
Browse By:ABCDEFGHIJKLMNOPQRSTUVWXYZ#All topics,List of companies,Sitemap
© 2023 PatSnap. All rights reserved.Legal | Privacy policy Modern Slavery Act Transparency Statement
Page generation time: Jun 25 2025
For better visiting experience, please use PC device.X